CoverMyTest partners with your lab to make Prior Authorization more efficient and effective at a lower cost with its CMT Laboratory Assist Program™
CMT is bringing innovative solutions to labs in the molecular diagnostics and precision medicine areas.
Andrew Mignatti – Co-Founder and CEO
Perry Dimas – Co-Founder and Chief Business Officer
CMT provides comprehensive market access services to all participants in the molecular diagnostics
arena, including patients, providers, laboratories, payors and IVD diagnostic manufacturers.
CMT leverages the molecular diagnostics and precision medicine market’s emerging need for prior
authorization solutions that has arisen from the growing number of payors that require PAs.